<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04128449</url>
  </required_header>
  <id_info>
    <org_study_id>UCAMCFE-0004</org_study_id>
    <nct_id>NCT04128449</nct_id>
  </id_info>
  <brief_title>Modifications in the Anaerob Threshold in Cyclists by Consuming Docosahexaenoic Acid (DHA)</brief_title>
  <acronym>MATCY</acronym>
  <official_title>Modifications in the Anaerob Threshold in Cyclists (DHA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Católica San Antonio de Murcia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad Católica San Antonio de Murcia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In a double-blind, parallel randomized clinical trial with 38 cyclists in whom the
      performance improvement was determined after the consumption of docosahexaenoic acid for one
      month.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2018</start_date>
  <completion_date type="Actual">June 30, 2018</completion_date>
  <primary_completion_date type="Actual">June 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>ergospirometry variable: heart rate</measure>
    <time_frame>The change was evaluated after one month of product consumption.</time_frame>
    <description>It was done with a bicycle with electromagnetic resistance (Spin Trainer ;Technogym). Heart rate was measured in beats per minute.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ergospirometry variable: absolute oxygen consumption</measure>
    <time_frame>The change was evaluated after one month of consumption of the product</time_frame>
    <description>It was done with a bicycle with electromagnetic resistance (Spin Trainer ;Technogym).It was measured in milliliters per minute</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ergospirometry variable:respiratory ratio</measure>
    <time_frame>The change was evaluated after one month of consumption of the product</time_frame>
    <description>It was done with a bicycle with electromagnetic resistance (Spin Trainer ;Technogym). Through the oxycon pro jaeger gas analyzer.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ergospirometry variable: oxygen equivalent</measure>
    <time_frame>The change was evaluated after one month of consumption of the product</time_frame>
    <description>It was done with a bicycle with electromagnetic resistance (Spin Trainer ;Technogym). Through the oxycon pro jaeger gas analyzer.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood variables: Natremia, potassium, chloremia, calcemia, , bicarbononatemia, ph, lactacidemia.</measure>
    <time_frame>The change was evaluated after one month of product consumption.</time_frame>
    <description>The following variables were analyzed: The variables are analyzed using the ABL 77 radiometer. The unit of measurement is mmol / L.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">38</enrollment>
  <condition>Performance</condition>
  <arm_group>
    <arm_group_label>docosahexaenoic acid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1,66 grams/24 hours (5 dragees)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>sunflower oil (5 dragees)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>docosahexaenoic acid</intervention_name>
    <description>5 dragees every 24 hours</description>
    <arm_group_label>docosahexaenoic acid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>5 dragees every 24 hours</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male between 18 and 75 years old.

          -  Cyclists who train three or four times a week.

        Exclusion Criteria:

          -  Suffering some type of chronic disease.

          -  Consume habitually pharmacological treatments that could influence the physiological
             or biochemical responses to be analyzed in the present work.

          -  Consumption in the month prior to the start of the study, or during the performance of
             the same, functional food enriched with omega-3 fatty acids.

          -  To present during the performance of the stress tests, any of the absolute or relative
             contraindications dictated by the American College of Sports Medicine (ACSM, 1999) 15
             would be duly informed and excluded from the present study.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Catholic University of Murcia</name>
      <address>
        <city>Murcia</city>
        <zip>30107</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>May 15, 2018</study_first_submitted>
  <study_first_submitted_qc>October 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 16, 2019</study_first_posted>
  <last_update_submitted>October 16, 2019</last_update_submitted>
  <last_update_submitted_qc>October 16, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad Católica San Antonio de Murcia</investigator_affiliation>
    <investigator_full_name>Francisco Javier López Román</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>performance</keyword>
  <keyword>cyclists</keyword>
  <keyword>docosahexaenoic acid</keyword>
  <keyword>anaerobic threshold</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

